Rx Medicare

Medicare News

Flower

Instanyl Sets New Standard In Management Of Breakthrough Cancer Pain

New data presented today, 11-Sep-2009, further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.

Read More…

  • Share/Bookmark

Related Posts

Tags: , , , , , ,

Comments are closed.